In total, we analyzed 8 breast cancers and 8 other CHEK2-deficient cancers [colorectal cancer (CRC) (n = 4), thyroid (n = 2), endometrial (n = 1), and urothelial (n = 1) cancer]. This evidence concerns the gene CHEK2 and breast carcinoma.